Selective degradation of oncogenic extrachromosomal DNA by type I-E CRISPR
Ensieh M. Poursani, Vu Pham, Anahid Ehteda, Orazio Vittorio
This study demonstrates that type I-E CRISPR can selectively degrade oncogenic extrachromosomal DNA in cancer cells, reducing oncogene signaling and tumor proliferation.